A detailed history of Boston Partners transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Boston Partners holds 3,314,939 shares of ZBH stock, worth $382 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
3,314,939
Previous 3,314,939 -0.0%
Holding current value
$382 Million
Previous $438 Million -0.0%
% of portfolio
0.54%
Previous 0.54%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$119.98 - $132.61 $82.9 Million - $91.7 Million
691,191 Added 26.34%
3,314,939 $438 Million
Q4 2023

Feb 07, 2024

SELL
$102.72 - $121.7 $7.3 Million - $8.65 Million
-71,084 Reduced 2.64%
2,623,748 $319 Million
Q3 2023

Nov 07, 2023

BUY
$110.76 - $143.18 $67.4 Million - $87.2 Million
608,959 Added 29.19%
2,694,832 $302 Million
Q2 2023

Aug 10, 2023

SELL
$126.43 - $145.6 $22.8 Million - $26.2 Million
-180,000 Reduced 7.94%
2,085,873 $304 Million
Q1 2023

May 09, 2023

SELL
$121.91 - $130.94 $45 Million - $48.4 Million
-369,517 Reduced 14.02%
2,265,873 $293 Million
Q4 2022

Feb 07, 2023

SELL
$104.7 - $128.4 $901,257 - $1.11 Million
-8,608 Reduced 0.33%
2,635,390 $336 Million
Q3 2022

Nov 09, 2022

SELL
$101.65 - $119.27 $15.1 Million - $17.7 Million
-148,395 Reduced 5.31%
2,643,998 $276 Million
Q2 2022

Aug 10, 2022

SELL
$102.23 - $133.85 $43.7 Million - $57.3 Million
-427,858 Reduced 13.29%
2,792,393 $293 Million
Q1 2022

May 10, 2022

BUY
$108.42 - $129.58 $16.4 Million - $19.5 Million
150,862 Added 4.92%
3,220,251 $412 Million
Q4 2021

Feb 04, 2022

BUY
$115.43 - $146.63 $73.3 Million - $93.1 Million
634,960 Added 26.08%
3,069,389 $390 Million
Q3 2021

Nov 05, 2021

BUY
$136.35 - $158.76 $33.7 Million - $39.3 Million
247,286 Added 11.31%
2,434,429 $356 Million
Q2 2021

Aug 12, 2021

BUY
$152.95 - $173.41 $7.66 Million - $8.68 Million
50,069 Added 2.34%
2,187,143 $352 Million
Q1 2021

May 10, 2021

BUY
$148.16 - $159.71 $29.2 Million - $31.5 Million
197,219 Added 10.17%
2,137,074 $342 Million
Q4 2020

Feb 04, 2021

SELL
$128.25 - $151.41 $131 Million - $154 Million
-1,018,382 Reduced 34.43%
1,939,855 $299 Million
Q3 2020

Nov 13, 2020

SELL
$113.59 - $141.68 $30.9 Million - $38.5 Million
-271,986 Reduced 8.42%
2,958,237 $403 Million
Q2 2020

Aug 12, 2020

SELL
$87.02 - $133.4 $17.2 Million - $26.4 Million
-197,645 Reduced 5.77%
3,230,223 $386 Million
Q1 2020

May 13, 2020

SELL
$78.28 - $155.73 $60.1 Million - $120 Million
-768,395 Reduced 18.31%
3,427,868 $346 Million
Q4 2019

Feb 05, 2020

BUY
$127.4 - $146.83 $42.4 Million - $48.9 Million
333,008 Added 8.62%
4,196,263 $628 Million
Q3 2019

Nov 20, 2019

SELL
$113.33 - $138.46 $177,588 - $216,966
-1,567 Reduced 0.04%
3,863,255 $530 Million
Q3 2019

Nov 08, 2019

BUY
$113.33 - $138.46 $198,780 - $242,858
1,754 Added 0.05%
3,864,822 $456 Million
Q2 2019

Aug 26, 2019

SELL
$108.87 - $125.09 $21,011 - $24,142
-193 Reduced -0.0%
3,863,068 $455 Million
Q2 2019

Aug 09, 2019

BUY
$108.87 - $125.09 $230 Million - $264 Million
2,108,782 Added 120.19%
3,863,261 $455 Million
Q1 2019

May 03, 2019

BUY
$97.5 - $125.79 $65.4 Million - $84.3 Million
670,501 Added 61.86%
1,754,479 $224 Million
Q4 2018

Feb 07, 2019

BUY
$94.4 - $126.76 $43.5 Million - $58.5 Million
461,269 Added 74.07%
1,083,978 $112 Million
Q3 2018

Nov 14, 2018

BUY
$108.41 - $127.64 $2.68 Million - $3.16 Million
24,718 Added 4.13%
622,709 $81.9 Million
Q2 2018

Aug 03, 2018

BUY
$102.12 - $114.04 $2.9 Million - $3.24 Million
28,415 Added 4.99%
597,991 $66.6 Million
Q1 2018

May 04, 2018

BUY
$104.31 - $124.46 $1.36 Million - $1.63 Million
13,062 Added 2.35%
569,576 $62.1 Million
Q4 2017

Feb 01, 2018

SELL
$105.55 - $120.83 $40.5 Million - $46.3 Million
-383,477 Reduced 40.8%
556,514 $67.2 Million
Q3 2017

Nov 02, 2017

BUY
$106.92 - $117.79 $101 Million - $111 Million
939,991
939,991 $110 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $24.2B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.